Platelet intracellular signaling and apoptotic machinery

Platelet intracellular signaling pathways and apoptotic machinery encompass the complex biochemical networks that regulate platelet activation, aggregation, and lifespan. Signaling is primarily initiated by surface receptors such as G protein-coupled receptors (P2Y12, PAR1) and glycoprotein complexes (GPVI, αIIbβ3), which trigger downstream cascades involving calcium mobilization and protein kinase activation [PMID: 20403477]. The apoptotic machinery in platelets is governed by the intrinsic pathway, where the balance between pro-apoptotic (Bak, Bax) and anti-apoptotic (Bcl-xL) proteins determines platelet survival and clearance [PMID: 17962556]. Dysregulation of these pathways is central to the pathogenesis of arterial thrombosis and cardiovascular diseases, making them critical focuses for antiplatelet therapy [PMID: 15509692]. Drugs like aspirin and P2Y12 inhibitors target signaling to prevent clot formation, while certain chemotherapeutics can inadvertently trigger the apoptotic machinery, leading to thrombocytopenia [PMID: 21415264]. Understanding the interplay between activation signaling and programmed cell death is essential for developing safer antithrombotic agents and managing drug-induced platelet disorders.

Other names

Platelet activation pathwaysPlatelet programmed cell deathPlatelet signal transductionPlatelet apoptosis

Inhibition of platelet aggregation through receptor antagonism or enzyme inhibition, and modulation of cell survival via BCL-2 family proteins.